Standout Papers
- Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial) (2003)
- National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report (2015)
Immediate Impact
2 by Nobel laureates 11 from Science/Nature 83 standout
Citing Papers
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
2024 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
Works of Peter H. Jones being referenced
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
2015 Standout
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial)
2003 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Peter H. Jones | 4258 | 2265 | 988 | 1280 | 135 | 6.9k | |
| Ioanna Gouni‐Berthold | 3911 | 1727 | 895 | 1002 | 154 | 7.2k | |
| James H. McKillop | 5050 | 2474 | 973 | 1588 | 115 | 8.6k | |
| Deborah R. Shapiro | 4860 | 2250 | 1005 | 1529 | 79 | 9.4k | |
| Adrienne Kirby | 5250 | 2171 | 1051 | 1720 | 97 | 9.3k | |
| Neeraj Bhala | 4427 | 1858 | 706 | 1368 | 74 | 8.4k | |
| Ming‐Shyan Lin | 3327 | 1782 | 837 | 667 | 156 | 6.6k | |
| Tamio Teramoto | 2541 | 1667 | 653 | 579 | 208 | 5.4k | |
| A R Lorimer | 5843 | 3194 | 1283 | 1612 | 111 | 9.3k | |
| Michael Clearfield | 5774 | 2958 | 1258 | 1612 | 64 | 8.4k | |
| Heinz Drexel | 4122 | 2580 | 905 | 1129 | 295 | 8.4k |
All Works
Loading papers...